Iantrek Announces Peer-Reviewed Publication Highlighting 12-Month Safety and Effectiveness Results for its Bio-Interventional Uveoscleral Outflow Technology in Open-Angle Glaucoma Patients
10 déc. 2024 08h00 HE
|
Iantrek, Inc.
White Plains, Dec. 10, 2024 (GLOBE NEWSWIRE) -- White Plains, NY – December 10, 2024 – Iantrek, Inc., a venture-backed, medical technology company pioneering next-generation bio- and...
Glaucoma Therapeutics Strategic Industry Report 2024 - Growth in Specialty Eye Clinics Enhancing Treatment Reach
09 déc. 2024 11h03 HE
|
Research and Markets
Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "Glaucoma Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Glaucoma...
SpyGlass Pharma Completes Enrollment in Phase I/II Study of its Promising Long-Term Drug Delivery Platform for Glaucoma and Ocular Hypertension
19 nov. 2024 08h00 HE
|
SpyGlass Pharma, Inc.
SpyGlass prepares for End of Phase II meeting with the FDA to advance its Drug Delivery Platform into Phase III pivotal studiesInnovative platform has the potential to enable all cataract surgeons to...
SpyGlass Pharma Presents Promising 18-month Data of its Innovative Drug Delivery Platform Implanted During Routine Cataract Surgery in Eyes with Glaucoma
17 oct. 2024 14h35 HE
|
SpyGlass Pharma, Inc.
Mean intraocular pressure (IOP) was reduced by 43.7% from baseline at month 18All patients remained off topical IOP-lowering medications and achieved >20% IOP reductionAll eyes achieved Visual...
ONL Therapeutics Closes $65 Million in Oversubscribed Series D Financing
13 sept. 2024 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Sept. 13, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
ONL Therapeutics to Present at the 57th Annual Scientific Meeting of The Retina Society and EURETINA Innovation Spotlight
10 sept. 2024 07h00 HE
|
ONL Therapeutics
ANN ARBOR, Mich., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
iSTAR Medical continues to strengthen US presence with appointment of Chief Medical Officer and Vice President of Clinical Affairs
04 sept. 2024 07h00 HE
|
iSTAR Medical
For immediate release iSTAR Medical continues to strengthen US presence with appointment of Chief Medical Officer and Vice President of Clinical Affairs WAVRE, Belgium — 4 September 2024: iSTAR...
Global Next Generation Contact Lenses & Visual Prostheses Market to Reach USD 715.57 Million by 2030
12 août 2024 04h12 HE
|
Research and Markets
Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "Global Next Generation Contact Lenses & Visual Prostheses Market by Product (Diagnostic or monitoring contact lenses, Drug-eluting contact lenses,...
Global Optometry Equipment Market Set to Reach USD 1.68 Billion by 2028
12 juin 2024 10h30 HE
|
Research and Markets
Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Global Optometry Equipment Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The global optometry equipment market is...
Global Tonometer Market Forecast Report 2024-2029, with Profiles of Haag-Streit, HEMC Medical, Reichert Technologies, Diaton, Jaggi Brothers, Advin Healthcare, Keeler, Takagi Japan, Inami & Nidek-Intl
27 mai 2024 07h32 HE
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Tonometer Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. The tonometry industry is experiencing...